Changes in Glycemic Control and Body Mass Index in Left Ventricular Assist Device Patients with Diabetes

Patients with type 2 diabetes mellitus (DM) and systolic heart failure (HF) often show improved glycemic control and reduced diabetes medication requirements after left ventricular assist device (LVAD) implantation. However, LVAD recipients also show increased body mass index (BMI) over time. We sought to determine whether post-LVAD improvements in hemoglobin A1c (HbA1c) are affected by changes in BMI.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Source Type: research